Implementing rotavirus vaccination in Asia

Mathuram Santosham1, E Anthony S Nelson, Joseph S Bresee

  • 1Department of International Health, Johns Hopkins University Bloomberg School of Public Health, 615 N. Wolfe Street, E8132, 621 N. Washington Street, Baltimore, MD 21205, USA. msantosh@jhsph.edu

Vaccine
|September 21, 2007
PubMed

Insights

Rotavirus vaccines are recommended for national immunization programs in Asia. Further data on disease burden and economic impact are needed for widespread implementation to reduce childhood illness.

Area of Science:

  • Pediatrics
  • Vaccinology
  • Public Health

Background:

  • Rotavirus is a significant cause of childhood morbidity and mortality in Asia.
  • The Asian Pacific Pediatric Association (APPA) and international experts convened to discuss rotavirus vaccine implementation.
  • Existing rotavirus vaccines are safe, well-tolerated, and efficacious, with more candidates in development.

Purpose of the Study:

  • To summarize recommendations for rotavirus vaccine integration into National Immunization Programmes (NIP) in Asian countries.
  • To highlight the need for additional disease burden and economic evaluation data for policy decisions.
  • To address implementation considerations, including co-administration with other vaccines.

Main Methods:

  • Expert consensus and discussion during the 2006 APPA meeting.
  • Review of existing rotavirus vaccine data (safety, efficacy).
  • Consideration of disease burden and economic evaluation requirements.

Main Results:

  • Strong recommendation for rotavirus vaccine use in Asian NIPs.
  • Agreement on the necessity of further disease burden data and economic evaluations for nationwide implementation.
  • Discussion of practical aspects like concomitant vaccine use.

Conclusions:

  • Rotavirus vaccines offer substantial potential to decrease rotavirus disease burden in Asian children.
  • Policy decisions on vaccine introduction require robust data and economic assessments.
  • Strategic implementation planning is crucial for maximizing vaccine impact on child health in Asia.

Related Concept Videos

Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Vaccinations01:51

Vaccinations

Overview
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Vaccine Production01:23

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...